| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |